Challenges and Approaches to Population Management of Long-Term Opioid Therapy Patients

Purpose: Primary care is challenged with safely prescribing opioids for patients with chronic noncancer pain (CNCP), specifically to address risks for overdose, opioid use disorder, and death. We identify sociotechnical challenges, approaches, and recommendations in primary care to effectively track and monitor patients on long-term opioid therapy, a key component for supporting adoption of opioid prescribing guidelines.

Methods: We examined qualitative data (field notes and postintervention interview and focus group transcripts) from 6 rural and rural-serving primary care organizations with 20 clinic locations enrolled in a study evaluating a practice redesign program to improve opioid medication management for CNCP patients. Two independent researchers used content analysis to categorize data into key themes to develop an understanding of sociotechnical factors critical to creating and implementing an approach to tracking and monitoring of patients on long-term opioid therapy in primary care practices.

Results: Four factors were critical to developing a tracking and monitoring system. For each we describe common challenges and approaches used by the clinics to overcome then. The first factor, buy-in and participation, was essential for accomplishing the other 3. The other factors occurred sequentially: 1) cohort identification-finding the right patients, 2) data collection and extraction-tracking the right data, and 3) data use-monitoring patients and adjusting care processes.

Conclusions: We identified common challenges and approaches to tracking and monitoring patients using long-term opioid therapy for CNCP in primary care. Based on these findings we provide recommendations to build capacity for tracking and monitoring for organizations that are engaged in improving safe opioid-prescribing practices for CNCP in primary care.

Author/s:

Stephens, Kari A., Ike, Brooke, Baldwin, Laura-Mae, Packer, Christine, Parchman, Michael

Dietary Supplement Ingredient Advisory List

Brian Desmarais — Sun, 19 May 2019 01:19:00 +0000

Date Added:

May 18, 2019

Publisher:

Food and Drug Administration

Publication Date:

May 8, 2019

URL:

Dietary Supplement Ingredient Advisory List

Type:

Public Health Announcements

Format:

Web Page

Keywords

MeSH

Tetrahydroisoquinolines

The FDA is warning consumers not to purchase dietary supplements containing four specific substances considered hazardous to health, andarine, higenamine, hordenine, and 1,4-DMAA, all of which have a variety of other names listed in the article.

James W. Mold, MD, MPH

Free full text

View

The FDA Dietary Supplement Ingredient Advisory List is intended to quickly alert the public when the FDA identifies ingredients that do not appear to be lawfully included in products marketed as dietary supplements.